TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Biognos AB
Closing information (x1000 DKK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
62
|
0
|
86 |
| Financial expenses |
0
|
0
|
1 |
| Earnings before taxes |
-558
|
-818
|
-860 |
| EBITDA |
-558
|
-813
|
-846 |
| Total assets |
1,698
|
404
|
390 |
| Current assets |
107
|
404
|
386 |
| Current liabilities |
207
|
280
|
256 |
| Equity capital |
861
|
124
|
134 |
| - share capital |
65
|
67
|
67 |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
50.7%
|
30.7%
|
34.4% |
| Turnover per employee |
62
|
0
|
86 |
| Profit as a percentage of turnover | -900% | -1000% | |
| Return on assets (ROA) |
-32.9%
|
-202.5%
|
-220.3% |
| Current ratio |
51.7%
|
144.3%
|
150.8% |
| Return on equity (ROE) |
-64.8%
|
-659.7%
|
-641.8% |
| Change turnover |
62
|
-86
|
-567 |
| Change turnover % |
-100%
|
-87% | |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.